Rhonda has more than 25 years of healthcare industry experience. She is a board certified internist and clinical pharmacologist with extensive pharmaceutical industry experience.
Rhonda's expertise in drug development ranges across translational medicine, clinical pharmacology, business development and outcomes research. Additionally, she has had executive-level experience in the Managed Care industry. At Foresite Capital, she is a member of the investment team and contributes to due diligence and evaluation of companies.
Most recently, Rhonda joined Foresite Capital after a 10-year career at Merck Research Laboratories, where she was a Vice President. During her tenure at Merck she helped establish several departments, including experimental medicine, regional deals in business development, emerging markets research and development, and outcomes research.
After graduating from Boston University, Rhonda completed her internship and residency in Internal Medicine at the Boston Veterans Administration Hospital, Boston, MA. Rhonda later completed a fellowship in Clinical Pharmacology and a Clinical Investigator Training Program at Tufts/Harvard-MIT Division of Health Sciences and Technology. Rhonda is a Diplomate in the American Board of Internal Medicine and the American Board of Clinical Pharmacology and maintains an active Medical License in the Commonwealth of Massachusetts.